A Novel Iron-Bioresorbable Sirolimus-Eluting Scaffold Device for Infrapopliteal Artery Disease

JACC Cardiovasc Interv. 2022 Mar 14;15(5):e57-e59. doi: 10.1016/j.jcin.2021.12.017. Epub 2022 Feb 9.

Authors

Guoyi Sun¹, Wei Guo², Hongpeng Zhang¹, Xiaohui Ma¹, Xin Jia¹, Jiang Xiong¹

Affiliations

¹ Vascular and Endovascular Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
² Vascular and Endovascular Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China. Electronic address: guoweiplagh@sina.com.

PMID: 35151611
DOI: 10.1016/j.jcin.2021.12.017

No abstract available

Keywords: bioresorbable scaffold; drug-eluting scaffold; infrapopliteal artery disease.

MeSH terms

Absorbable Implants
Arteries
Coronary Artery Disease*
Humans
Iron
Prosthesis Design
Sirolimus*
Treatment Outcome

Substances

Iron
Sirolimus